2022 COCA Calls/Webinars Information, Summaries, & Slide Sets

Title: What Clinicians Need to Know about Monkeypox in the United States and Multiple Countries

Date: Tuesday, May 24, 2022

Presenters:
Agam Rao, MD, FIDSA
CAPT, U.S. Public Health Service
Medical Officer, Poxvirus and Rabies Branch
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention

Laura Hinkle Bachmann, MD, MPH, FIDSA, FACP
Chief Medical Officer
Division of STD Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Control
Centers for Disease Control and Prevention

Brett Petersen, MD, MPH
CAPT, U.S. Public Health Service
Deputy Chief, Poxvirus and Rabies Branch
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention

David Kuhar, MD
Director, Office of Healthcare Worker Safety
Lead, Hospital Infection Prevention Team
Division of Healthcare Quality Promotion
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention


Title: Clinical Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology

Date: Thursday, May 19, 2022

Presenters:
L. Amanda Ingram, MPH
Epidemiologist Supervisor
Infectious Diseases & Outbreaks Division
Alabama Department of Public Health

Jacqueline Tate, PhD
Epidemiology Team Lead, Viral Gastroenteritis Branch
Division of Viral Diseases
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention

Helena Gutierrez, MD
Medical Director, Pediatric Liver Transplant Program
Assistant Professor, Division of Pediatric Gastroenterology, Hepatology, and Nutrition
The University of Alabama at Birmingham

Elizabeth A. Moulton, MD, PhD
Assistant Professor of Pediatrics
Transplant Infectious Diseases
Baylor College of Medicine
Texas Children’s Hospital


Title: Updated Guidance for Clinicians on COVID-19 Vaccines

Date: Thursday, May 5, 2022

Presenters:
Jennifer Cope, MD, MPH
Medical Officer
Post-COVID Conditions Team
Epidemiology Task Force
COVID-19 Response
Centers for Disease Control and Prevention

Michelle Haddad, PhD
Director of Post-COVID Neuropsychology Clinic
Director of Inpatient Neuropsychology
Departments of Rehabilitation Medicine & Neurology
Emory University School of Medicine

Jeffrey S. Fine, MD, FAAPMR
Associate Professor and Vice Chair, Rusk Rehabilitation
Dept of Rehabilitation Medicine and Dept of Medicine
NYU Langone Health

Talya K. Fleming, MD
Assistant Professor and Medical Director
JFK Johnson Rehabilitation Institute
Dept of Physical Medicine and Rehabilitation
Hackensack Meridian Medicine


Title: Updated Guidance for Clinicians on COVID-19 Vaccines

Date: Thursday, February 24, 2022

Presenters:
Sara Oliver, MD MSPH
LCDR, U.S. Public Health Service
Lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention

Elisha Hall, PhD, RD
Lead, Clinical Guidelines Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention

Evelyn Twentyman, MD, MPH
Chief Medical Officer, Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention


Title: COVID-19 Updates: What Clinicians Need to Know About Multisystem Inflammatory Syndrome in Children

Date: Thursday, February 10, 2022

Presenters:
Angela Campbell, MD, MPH, FAAP, FPIDS, FIDSA
Medical Officer
Multisystem Inflammatory Syndrome (MIS) Unit
COVID-19 Response
Centers for Disease Control and Prevention

Shana Godfred-Cato, DO, FAAP
Medical Officer
Multisystem Inflammatory Syndrome (MIS) Unit
COVID-19 Response
Centers for Disease Control and Prevention

Anna Yousaf, MD
Medical Officer
Multisystem Inflammatory Syndrome (MIS) Unit
COVID-19 Response
Centers for Disease Control and Prevention


Title: Updates to CDC’s COVID-19 Quarantine and Isolation Guidelines in Healthcare and Non-healthcare Settings

Date: Thursday, January 13, 2022

Presenters:
Lauri Hicks, DO
Captain, U.S. Public Health Service
Chief Medical Officer, COVID-19 Response
Director, Office of Antibiotic Stewardship
Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention

Alexander Kallen, MD, MPH
Chief, Prevention and Response Branch
Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention

Pragna Patel, MD, MPH
Deputy Principal Incident Manager, COVID-19 Response
Senior Medical and Science Advisor, HIV Prevention Branch
Division of Global HIV and TB
Centers for Disease Control and Prevention


Title: What Clinicians Need to Know About the New Oral Antiviral Medications for COVID-19

Date: Wednesday, January 12, 2022

Presenters:
Lauri Hicks, DO
Captain, US Public Health Service
Chief Medical Officer, COVID-19 Response
Director, Office of Antibiotic Stewardship
Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention

Colin Shepard, MD
CDC Liaison to the Assistant Secretary for Preparedness and Response (ASPR)
Center for Preparedness and Response
Centers for Disease Control and Prevention

Stephanie Troy, MD
Senior Medical Officer
Division of Antivirals
Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Aimee Hodowanec, MD
Senior Medical Officer
Division of Antivirals
Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Alice K. Pau, PharmD
Executive Secretary, NIH COVID-19 Treatment Guidelines Panel
Staff Scientist (Clinical)
Clinical Pharmacy Specialist
Division of Clinical Research
National Institute of Allergy & Infectious Diseases
National Institutes of Health


Sign up for COCA Newsletters and Announcements

Sign up to receive COCA Call Announcements, COCA Newsletters and other COCA resources by entering your email address:

Page last reviewed: January 7, 2022